Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients and pharmaceutical intermediates, cooperative R & D, custom manufacturing, sales and service as well as import of pharmaceutical raw materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic pharmaceutical companies, including pharmaceutical applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provides factory quality management system certification consulting services.
Internationally, we has long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provides API registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
Pfizer (USA)
- Profile: One of the world's largest biopharmaceutical companies, founded in 1849 and headquartered in New York State, USA. It has deployments in multiple therapeutic areas including oncology, vaccines, rare diseases, and inflammation.
- Key Anti-Inflammatory Products:
- Ibuprofen: A common non-steroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and anti-inflammatory effects, widely used to relieve mild to moderate pain (e.g., headache, joint pain, toothache) and fever caused by common cold or influenza.
- Etoricoxib: A selective cyclooxygenase-2 (COX-2) inhibitor for treating pain and inflammation in osteoarthritis, rheumatoid arthritis, etc.
- Manufacturing Advantages: Equipped with advanced production facilities and strict quality control systems, enabling large-scale and high-quality production of anti-inflammatory drugs. With production bases worldwide, its mature processes ensure product stability and consistency.
Roche (Switzerland)
- Profile: Founded in 1896 and headquartered in Basel, Switzerland, it leads globally in pharmaceuticals and diagnostics, covering drugs, diagnostics, and medical devices. It has numerous products in therapeutic areas like oncology, immune system diseases, ophthalmology, and infectious diseases.
- Key Anti-Inflammatory Products:
- Meloxicam: An enolic acid-type NSAID with strong anti-inflammatory, analgesic, and antipyretic effects, used for rheumatoid arthritis, osteoarthritis, etc.
- Celebrex (developed by Pfizer): Main ingredient celecoxib, a selective COX-2 inhibitor to reduce inflammation and pain for various inflammatory diseases.
- Manufacturing Advantages: Roche operates multiple advanced pharmaceutical plants globally, with cutting-edge production technologies, especially in biologic manufacturing to ensure product quality and activity. Its plants strictly follow Good Manufacturing Practice (GMP) standards, guaranteeing reliable product quality.
Novartis (Switzerland)
- Profile: Founded in 1873 and headquartered in Geneva, Switzerland, it is a global pharmaceutical company with deep R&D and manufacturing capabilities in oncology, immunology, cardiovascular, ophthalmology, etc.
- Key Anti-Inflammatory Products:
- Ibuprofen Sustained-Release Capsules: Relieve mild to moderate pain and fever from colds. The sustained-release formulation allows slow drug release for extended efficacy.
- Diclofenac Diethylamine Emulgel: A topical NSAID absorbed through the skin, effectively relieving mild to moderate pain and inflammation in muscles, soft tissues, and joints.
- Manufacturing Advantages: Novartis' global pharmaceutical plants feature advanced equipment and technologies, with rich experience in drug formulation R&D and production, enabling the manufacture of various anti-inflammatory drug formulations to meet diverse patient needs. The company also emphasizes environmental protection and sustainable development, adopting measures to reduce environmental impact during production.
Johnson & Johnson (USA)
- Profile: A diversified healthcare company founded in 1886 and headquartered in New Jersey, USA. Its businesses cover pharmaceuticals, medical devices, and consumer products, with wide influence in the global healthcare industry.
- Key Anti-Inflammatory Products:
- Remicade (infliximab): A tumor necrosis factor-α (TNF-α) inhibitor for rheumatoid arthritis, Crohn's disease, ulcerative colitis, etc., effectively reducing inflammation and improving quality of life.
- Manufacturing Advantages: Johnson & Johnson operates multiple pharmaceutical plants globally with strict production management and a sound quality control system. Its advanced biopharmaceutical production technologies ensure the quality and safety of biological agents. The company also focuses on R&D innovation, continuously investing in new anti-inflammatory drugs and production processes.
Merck & Co. (USA)
- Profile: Founded in 1891 and headquartered in New Jersey, USA, it is a global pharmaceutical company with significant status in vaccines, prescription drugs, and animal health, boasting strong R&D capabilities in oncology, immunology, diabetes, etc.
- Key Anti-Inflammatory Products:
- Dexamethasone Sodium Phosphate Injection: A glucocorticoid with potent anti-inflammatory, anti-allergic, and anti-shock effects, widely used in treating various inflammatory and allergic diseases (e.g., severe septic shock, allergic dermatitis, rheumatoid arthritis).
- Manufacturing Advantages: Merck's pharmaceutical plants feature advanced production technologies and strict quality control standards, capable of manufacturing high-quality chemical synthetic drugs and biological agents. The company has a complete global supply chain system to ensure timely drug delivery to markets worldwide.
AstraZeneca (UK-Sweden)
- Profile: Formed by the merger of the UK's SmithKline Beecham and Sweden's Astra in 1999, headquartered in Cambridge, UK. It has outstanding performance in therapeutic areas such as oncology, respiratory, cardiovascular, and metabolism.
- Key Anti-Inflammatory Products:
- Fluticasone Propionate/Salmeterol (Advair Diskus): An inhaled medication for asthma and chronic obstructive pulmonary disease (COPD). Fluticasone propionate has anti-inflammatory effects to reduce airway inflammation, while salmeterol is a long-acting β₂-receptor agonist to relax bronchial smooth muscles, jointly controlling respiratory inflammation and relieving symptoms.
- Manufacturing Advantages: AstraZeneca operates multiple modern pharmaceutical plants globally, emphasizing close integration of R&D and production to rapidly transform R&D achievements into actual products. Its plants excel in drug formulation technologies, especially in inhalant production, ensuring drug stability and precise dosing.
GlaxoSmithKline (GSK, UK)
- Profile: Headquartered in London, UK, it is a global healthcare company with extensive businesses in vaccines, pharmaceuticals, and consumer healthcare.
- Key Anti-Inflammatory Products:
- Fluticasone Propionate Inhalation Aerosol (Flixotide): An inhaled glucocorticoid for preventing and treating asthma, effectively reducing airway inflammation and lowering the frequency and severity of asthma attacks.
- Manufacturing Advantages: GSK owns advanced production facilities and strict quality control processes, with all global pharmaceutical plants adhering to high-standard production norms. The company has rich experience in respiratory drug production, ensuring the quality and efficacy of inhalants.
Eli Lilly and Company (USA)
- Profile: Founded in 1876 and headquartered in Indiana, USA, it is a global pharmaceutical company with important products in therapeutic areas such as diabetes, oncology, and neuroscience.
- Key Anti-Inflammatory Products:
- Cimzia (certolizumab pegol): A pegylated humanized anti-TNF-α monoclonal antibody fragment for rheumatoid arthritis, Crohn's disease, etc., with good anti-inflammatory effects and high safety.
- Manufacturing Advantages: Lilly's pharmaceutical plants adopt advanced production technologies and equipment, strictly complying with GMP. The company invests heavily in biologic production and R&D, continuously improving production processes to ensure product quality and effectiveness.
Bayer (Germany)
- Profile: Founded in 1863 and headquartered in Leverkusen, Germany, it is a global technology company with wide businesses in pharmaceuticals, agriculture, materials science, etc. In pharmaceuticals, it covers multiple therapeutic areas including cardiovascular diseases, oncology, and inflammation.
- Key Anti-Inflammatory Products:
- Aspirin: A classic Bayer product with anti-inflammatory, antipyretic, and analgesic effects. Low-dose aspirin is commonly used to prevent cardiovascular diseases, while larger doses relieve symptoms of inflammatory diseases like rheumatoid arthritis.
- Manufacturing Advantages: Bayer has long-standing and technologically advanced pharmaceutical plants with mature production processes and strict quality control. It has deep technical accumulation in chemical synthetic drug production, ensuring product quality and stability.